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The role(s) of the novel stargazin-like -subunit proteins remain controversial. We have shown previously that the neuron-specific 7
suppresses the expression of certain calcium channels, particularly CaV2.2, and is therefore unlikely to operate as a calcium channel
subunit. We now show that the effect of 7 on CaV2.2 expression is via an increase in the degradation rate of CaV2.2 mRNA and hence a
reduction of CaV2.2 protein level. Furthermore, exogenous expression of 7 in PC12 cells also decreased the endogenous CaV2.2 mRNA
level. Conversely, knockdown of endogenous 7 with short-hairpin RNAs produced a reciprocal enhancement of CaV2.2mRNA stability
and an increase in endogenous calcium currents in PC12 cells.Moreover, both endogenous and expressed7 are present on intracellular
membranes, rather than the plasmamembrane. The cytoplasmic C terminus of7 is essential for all its effects, andwe show that7 binds
directly via its C terminus to a heterogeneous nuclear ribonucleoprotein (hnRNP A2), which also binds to a motif in CaV2.2 mRNA, and
is associated with native CaV2.2 mRNA in PC12 cells. The expression of hnRNP A2 enhances CaV2.2 IBa , and this enhancement is
prevented by a concentration of 7 that alone has no effect on IBa. The effect of 7 is selective for certainmRNAs because it had no effect
on2-2mRNA stability, but it decreased themRNA stability for the potassium-chloride cotransporter, KCC1, which contains a similar
hnRNP A2 binding motif to that in CaV2.2 mRNA. Our results indicate that 7 plays a role in stabilizing CaV2.2 mRNA.
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Introduction
Voltage-dependent calcium channels (CaV) are heteromultimers
consistingof apore-forming1 subunit, assembledwithauxiliary,
2, and possibly  subunits (for review, see Catterall, 2000; Dol-
phin, 2003a,b). The role(s) of the  subunits in relation to calcium
channel functionremainsunclear.The firstCaV subunit tobe iden-
tified was 1, which copurifies with the skeletal muscle calcium
channel complex (Jay et al., 1991; Powers et al., 1993). In skeletal
muscle, the 1 subunit appears to have a suppressive effect, because
1 knock-out mice exhibit increased skeletal muscle calcium cur-
rents (Freise et al., 2000). After the identification of stargazin (2)
(Letts et al., 1998), subsequent studies have identified six additional
putative subunits (3–8) (Black andLennon, 1999;Burgess et al.,
1999, 2001; Klugbauer et al., 2000; Moss et al., 2002). However, it is
unclearwhether anyof these novel stargazin-likeproteins (2–8)
play any role as subunits of voltage-gated calcium channels. All
members of this family are thought to possess four transmembrane-
spanning domains with intracellular N and C termini. The 2, 3,
4, and 8 subunits form a subfamily exclusively localized to the
CNS (Letts et al., 1998; Klugbauer et al., 2000; Sharp et al., 2001;
Moss et al., 2003) whose interaction and functional modulation of
CaV channels has been investigated in several studies (Letts et al.,
1998; Klugbauer et al., 2000; Kang et al., 2001; Rousset et al., 2001;
Sharp et al., 2001; Moss et al., 2003) but which are now thought
primarily to represent trafficking proteins for the AMPA subtype of
glutamate receptors (TARPS) (Tomita et al., 2003, 2004). However,
they might also provide a bridge between calcium channels and
AMPA receptors (Kang et al., 2006). Furthermore, 7, despite not
having a classical C-terminal PDZ (postsynaptic density-95/Discs
large/zona occludens-1) binding domain, has also been shown re-
cently to have effects on AMPA receptor trafficking (Kato et al.,
2007).
The 7 and 5 proteins are predicted to represent a distinct
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subfamily of stargazin-related proteins (Burgess et al., 2001; Chu
et al., 2001; Moss et al., 2002), with extremely low sequence iden-
tity to 1 and25% identity to 2,mainly in the transmembrane
domains. We showed that coexpression of the 7 subunit with
CaV2.2 almost abolished the functional expression andmarkedly
suppressed the level of CaV2.2 1 subunit protein (Moss et al.,
2002). It also had smaller suppressive effects on CaV2.1 and
CaV1.2 currents (Moss et al., 2002). Our conclusion was that 7
was not a subunit of these calcium channels. Nevertheless, be-
cause of the marked effect of 7 on calcium channel expression
and because bothN-type calcium channels and 7 are specifically
expressed in neuronal tissue, we have now examined the mecha-
nism of action of 7 to probe its physiological function.
The present results indicate that 7 is involved in regulating the
stability of specific mRNAs, including CaV2.2. We propose that the
mechanism may involve 7 sequestering a specific mRNA binding
protein, thus compromising the stability of CaV2.2 mRNA.
Materials andMethods
cDNA constructs. The following cDNAs were used: CaV2.2 (GenBank
accession number D14157) and CaV2.2 3 untranslated region, CaV3.1
(GenBank accession number AF027984),1b (GenBank accession num-
ber X61394; fromDr. T. P. Snutch, University of British Columbia, Van-
couver, British Columbia, Canada), 2-2 (GenBank accession number
AF247139, common brain splice variant), 7 (GenBank accession num-
ber NM031896), mut-3b green fluorescent protein (GFP) (GenBank ac-
cession numberM62653, except S72A and S65G; fromDr. T. E. Hughes,
Montana State University, Bozeman, MT), mouse KCC1 (GenBank ac-
cession number AF121118), KV3.1b (GenBank accession number
M68880), heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1)
(GenBank accession number BC070315), and hnRNP A2–RGG (Ni-
chols et al., 2000). Truncated and tagged 7 constructs and hemaggluti-
nin (HA)-tagged hnRNP A2 were generated using standard molecular
biological techniques and confirmed by DNA sequencing. All constructs
were cloned into the pMT2 expression vector (Swick et al., 1992), except
7–HA and 7–cyan fluorescent protein (CFP), hnRNPA2–RGG, and
KCC1, all of which were in pcDNA3.1, except 7–CFP in pECFP–N1,
Kv3.1b in pRC–CMV, and hnRNP A1 in pCGT7. pDsRed2–endoplas-
mic reticulum (ER) plasmid was used in some experiments (Clontech).
Short-hairpin RNA design and expression plasmid. siSearch (http://
sonnhammer.sbc.su.SE/databases.html) and Jura (http://jura.wi.mit.
edu/siRNAext/) software was used to design 19-nucleotide sequences
corresponding to human and rat 7 genes. Databases were searched to en-
sure that these sequences were not homologous to any other known genes.
Rat 7 (GenBank accession number AF361345) targets are as follows: 7
96 (5-CTGGCTGTATATGGAGGAG-3), 7 285 (5-GACAGTACG-
CACGGCTACA-3), and 7 500 (5-CTGAGCAATACTTTCACTA-3).
Human 7 (GenBank accession number AF458897) targets are as follows:
7 96 (5-CTGGCTGTACATGGAAGAA-3), 7 285 (5-GACAGTGCG-
CACGGCCACC-3), and 7 107 (5-TGGAAGAAGGCACAGTGCT-3).
Then, for each target, two oligonucleotides (A and B) were synthesized (In-
vitrogen). Oligonucleotide A contains a 5 overhang (TTTG) for ligation
into a BpiI (BbsI) site, the sense and the antisense of these sequences linked
by a hairpin loop of 9 bases [TTCAAGAGA (Brummelkamp et al., 2002)],
and a TTTTT sequence corresponding to a termination for transcription
of small RNAs by RNA polymerase III; oligonucleotide B contains a 5
overhang (CTAG) for ligation into an XbaI site and 52 nucleotides corre-
sponding to the reverse complement of the last 52 nucleotides of oligonu-
cleotide A. Forward and reverse strands were annealed and subcloned
downstream a U6 promoter into pG418–shRNA–Empty linearized with
XbaI and BpiI. pG418–shRNA–Empty is a pBSII plasmid containing a
mouse U6 promoter and a neomycin (G418) resistance cassette. A negative
control short-hairpin RNA (shRNA), directed against Drosophila gene gnu
(Xu and Shrager, 2005) and a positive control shRNA directed against
c-jun (Lingor et al., 2005), were also synthesized. Correct orientation and
location of oligonucleotide cloning were confirmed by sequencing the
plasmids. Validation of the plasmid in PC12 cells was determined by its
ability to knockdown c-jun (supplemental Fig. 1, available at www.
jneurosci.org as supplemental material).
Antibodies against 7. The 7 tail polyclonal rabbit antibody (Ab)
raised against the C-terminal peptide YPPAIKYPDHLHIS has been de-
scribed previously (Moss et al., 2002). A 7 loop Ab was also raised
against the peptide VASEYFLEPEINLVTEN, in the loop between trans-
membrane segments 1 and 2 of 7. These Abs do not recognize any of the
other  proteins tested (2–4) (supplemental Fig. 2A–C, available at
www.jneurosci.org as supplemental material).
Cell culture and transfection. COS-7 cells were cultured as described
previously (Campbell et al., 1995). The tsA 201 cells were cultured in
DMEM with 10% fetal bovine serum (FBS) and 1% L-glutamine. Cells
were transfected using either Geneporter (Qbiogene) or Fugene6 (Roche
Diagnostics), with equivalent results. The cDNAs (all at 1 g/l) for
CaV1, 2-2, 1b, 7, and GFP when used as a reporter of transfected
cells, were mixed in a ratio of 3:1.5:2:1.5:1:0.2, unless otherwise stated.
When particular subunits were not used, the volume was made up with
Tris–EDTA (10 mM Tris and 1 mM EDTA, pH 7), or blank vector, or the
volume of transfection reagent was reduced, with equivalent results. In
some experiments, cDNA for the nonconducting potassium channel
Kir2.1–AAA (Tinker et al., 1996) was used as control for the presence of
7, also with equivalent results to the use of blank vector.
PC12 cells were grown in DMEM, 7.5% FBS, and 7.5% horse serum.
For electrophysiology, PC12 cells were transiently transfected with cD-
NAs for GFP and/or 7, using Fugene6. Differentiation was with serum-
free medium containing NGF (100 ng/ml murine 7s NGF; Invitrogen),
replenished every 48 h. Cells were used for recording after 5–7 d of
differentiation. For the generation of stable cell lines, PC12 cells were
transfectedwith 7–HAor 7–CFP, and clonal cell lines were established
by standard techniques, using 400 g/ml Geneticin (Invitrogen) for se-
lection. The culture medium was subsequently supplemented with 400
g/ml Geneticin (Invitrogen).
To obtain high transfection rates with shRNAs, PC12 cells were trans-
fected using anAmaxaNucleofector, according tomanufacturer instruc-
tions. TheDNAmix contained 2g of shRNAplasmid and 0.5g ofGFP
or yellow fluorescent protein (YFP) as a reporter of transfected cells. Cells
were used 4–5 d after transfection with shRNA.
For primary culture of superior cervical ganglion (SCG) neurons, rats
were killed by either CO2 inhalation or cervical dislocation, according to
United Kingdom Home Office Schedule 1 Guidelines. SCGs were dis-
sected from rats at postnatal day 17. Ganglia were desheathed and lightly
gashed before successive collagenase (Sigma) and trypsin (Sigma) treat-
ment, both at 3mg/ml. To produce a single-cell suspension, ganglia were
dissociated by trituration and centrifugation. Dissociated cells were
plated onto glass-bottomed plates (MatTek) precoated with laminin
(Sigma), using one ganglion per five plates. Cells were maintained with
Liebovitz L-15medium (Sigma), supplementedwith 24mMNaHCO3, 10%
FBS (Invitrogen), 33 mM glucose (Sigma), 20 mM L-glutamine, 1000 IU of
penicillin, 1000 IU of streptomycin (Invitrogen), and 50 ng/ml NGF.
Microinjection. cDNAs were injected into SCG neurons 18–24 h after
they were placed in culture. Microinjection was performed using an Ep-
pendorf microinjection system on a Carl Zeiss Axiovert 200M micro-
scope using the following settings: 100–150 hPa injection pressure, an
injection time of 0.2 s, and constant pressure of between 40 and 50 hPa.
The cDNAs were injected at 50 ng/l diluted in 200 mM KCl.
Measurement of mRNA levels by quantitative PCR. RNA was isolated
using RNeasy columns (Qiagen), including an on-column DNase step.
Reverse transcription (RT) was performed using randomhexamer prim-
ers andMoloneymurine leukemia virus reverse transcriptase (Promega)
at 37°C for 2 h. The quantitative PCR (q-PCR) was performed with an
iCycler (Bio-Rad) using the iQ SYBR supermix. For each set of primers
and for every experiment, a standard curve was generated using a serial di-
lution of reverse-transcribed RNA combined from several samples. For
q-PCR in PC12 cells, the following primers were used: rat CaV2.2 (Gen-
Bank accession number NM147141), 5-GGCAAGAAGGAGGCAGAG-3
and 5-GCAGAAGCGACGGAGTAG-3; rat 7 (GenBank accession
number AF361345), 5-CTACTCGGGCCAGTTTCTGC-3 and 5-GC-
CGGAGGGTAATTTTGC-3; and rat glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) (GenBank accession number AF106860), 5-
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ATGACTCTACCCACGGCAAG-3 and 5-CATACTCTGCACCAGCA-
TCTC-3. Data were normalized for expression of GAPDHmRNA.
For measurement of mRNA degradation rates, q-PCR of transcript
levels was performed in Xenopus oocytes. Plasmid cDNAs were injected
intranuclearly for CaV2.2, 1b, and 2-2, either with or without 7.
After 24 h, oocytes were incubated for the stated times with actinomycin
D (50 g/ml). RNA extraction, RT, and q-PCR
were performed as described above. The follow-
ing primers were used: CaV2.2, 5-CTCTG-
CGCTTACTGAGAATC-3 and 5-AACAGGA-
AGAGCAGGAAGAG-3; 18S, 5-TGACTCAA-
CACGGGAAACCT-3 and 5-AATCGCTCC-
ACCAACTAAGAAC-3; 22, 5-GGTATTT-
GCTGCCACTGATG-3 and 5-AGGCTGCGA-
CGGTAGAAG-3; and KCC1, 5-AGCATAAG-
GTTTGGAAGAAGTG-3 and 5-CAGGCG-
GAGGTGATACAG-3. Data were normalized
for expression of 18S ribosomal RNA.
Oligoribonucleotide binding to hnRNP A2.
This was performed as described previously
(Hoek et al., 1998), with the exception that
mouse brain, rather than rat brain, was used as a
source of hnRNPA2. The following RNAoligo-
nucleotides were used: A2 response element
(A2RE) 5 biotin, GCCAAGGAGCCA-
GAGAGCAUG-3; CaV2.2 5 biotin, GC-
CAAGGAGCGGGAGCGAGUC-3; and non-
specific 5 biotin, CAAGCACCGAACCCGC-
AACUG-3. A2RE and nonspecific sequences
are identical in base composition (Hoek et al.,
1998). Proteins were taken up in 200 l of SDS
sample buffer and heated at 65°C for 10 min.
Twentymicroliters of each was run on a 4–12%
Bis–Tris gel, and Western blotting and immu-
nodetection was performed with anti-hnRNP
A2 Ab (Autogen Bioclear, 1:200).
Yeast two-hybrid assay. Assays were per-
formed using the MATCHMAKER GAL4 two
hybrid system (Clontech). Fragments of
hnRNP A2 (amino acids 1–177 or 178–342),
the 7 C terminus (201–275), the CaV2.2 I–II
loop (360–483), and CaV1b were generated
by PCR and subcloned in-frame into the vec-
tors pACT2 and pAS2-1. Plasmids were co-
transformed into the yeast strain Y190, and
transformants were selected by plating ontomin-
imal selective dropout (SD) -Leu, -Trp agar. Pro-
tein interactions were identified by restreaking
colonies onto SD -Leu, -Trp, -His plates and
performing colony-lift -galactosidase assays
or growth assays in the presence of 10 mM
3-amino-1,2,4-triazole, according to the sup-
plied protocol.
Immunoprecipitation. 7–HA was immuno-
precipitated from stably transfected PC12 and
transiently transfected tsA 201 cells. Endoge-
nous 7 and hnRNP A2 proteins were immu-
noprecipitated from untransfected PC12 cells.
The following general method was used. Cells
were washed with ice-cold PBS (Sigma-
Aldrich) and harvested in PBS with 10 mM
EDTA and protease inhibitor cocktail (Roche
Diagnostics). Cells were lysed and protein solu-
bilized by agitation with extraction buffer (1%
Igepal, 20 mM Tris, 150 mM NaCl, 1 mM EDTA,
0.5% sodium deoxycholate, 0.1% SDS, and
protease inhibitor cocktail, pH 7.4) for 30 min
at 4°C. Insoluble material was removed by cen-
trifugation at 40,000  g for 1 h at 4°C. The
supernatantwas clearedwith 50g of proteinG
linked to agarose beads (Sigma) for 2 h at 4°C. The supernatant was
incubated with 2 g of high-affinity anti-HA Ab (clone 3F10; Roche
Diagnostics), 7 C-terminus Ab, or hnRNP A2 monoclonal Ab EF-67
(SantaCruzBiotechnology), overnight at 4°Cwith constant agitation. An
additional 20 g of protein G linked to agarose beads was added and
Figure 1. Effect of C-terminal truncation of 7 on CaV2.2/1b/2-2 and CaV3.1 currents. A, Linearized diagram of 7,
indicating the approximate positions of the four transmembrane (TM) segments (black bars), the N-glycosylation site (V) at N45,
and the position of the truncations at amino acids 217, 238, and 271. B, Left, Example traces elicited after cDNA injection into
Xenopus oocytes by 100 ms step depolarizations to between40 and 0 mV from a holding potential of100 mV for CaV2.2/
1b/2-2 (top), plus7 (middle) and plus7 (1–217) (bottom). The charge carrier was 10mM Ba 2. The symbols beside the
traces refer to the relevant data in the current–voltage relationship (right); CaV2.2/1b/2-2 (f;n19) plus7(1–217) (‚;
n 18) and plus7 (; n 8). Data are fit by amodified Boltzmann function as described inMaterials andMethods, with V50,
act of9.9,9.8, and1.2 mV, respectively, and Gmax of 19.6, 16.6, and 5.9S, respectively. C, Mean percentage of control
peak IBa for CaV2.2/1b/2-2 currents (black bar; n 29) when coexpressed with 7 (white bar; n 31) or its truncated
constructs,7(1–217) (hatchedbar;n15),7(1–238) (graybar;n12), and7(1–271) (stripedbar;n16). The statistical
significances compared with control are **p  0.01. There was no effect of any of the constructs on the voltage for 50%
steady-state inactivation, which from combined experiments was60.2	 0.8 mV for controls (n 16),58.6	 1.0 mV in
the presence of 7 (n 7),61.7	 3.6 mV for 7(1–217) (n 5), and59.8	 1.0 mV for 7(1–271) (n 5). D,
Representative traces of peak Ba 2 currents in tsA 201 cells, cotransfected with CaV2.2,1b and2-2 with pMT2 as control
(con) compared with7 (panel 1),7(1–217) (panel 2), and7(stop) (panel 3). Panel 4 shows CaV3.1 expression with pMT2 as
control (con) comparedwith7. Currentswere elicited by depolarization to5mV (CaV2.2, 1mMBa
2) or10mV (CaV3.1, 10
mM Ba 2), from a holding potential of100 mV. Calibration bars refer to all traces for CaV2.2. E, Mean inhibition of Ba
2
currents (expressed as percentage of control	 SEM) induced by coexpression of CaV2.2with7 (white bar; n 21),7(1–217)
(black bar; n 15), 7(stop) (hatched bar; n 28), or CaV3.1 with 7 (cross-hatched bar; n 29). Statistical significance
compared with the current size without7, **p 0.01, Student’s t test.
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incubated for 2 h at 4°Cwith constant agitation.
Beads were washed twice with a high detergent
buffer (1% Igepal, 20 mM Tris, 150 mM NaCl, 1
mM EDTA, and protease inhibitor cocktail, pH
7.4), twice with a high-salt buffer (0.1% Igepal,
20 mM Tris, 500 mM NaCl, 1 mM EDTA, and
protease inhibitor cocktail, pH 7.4), and twice
with a low-salt buffer (0.1% Igepal, 20 mM Tris,
1 mM EDTA, and protease inhibitor cocktail,
pH 7.4). Bound protein was removed from the
beads by the addition of lauryl dodecyl sulfate
(LDS) sample buffer with reducing agent (In-
vitrogen) and heating to 65°C for 10 min. Sam-
ples containing immunoprecipitated endoge-
nous 7 were treated with LDS buffer as above
and eluted proteins concentrated by precipita-
tion with ice-cold acetone before resuspension
in fresh LDS buffer for PAGE.
For protein sequencing, samples were sepa-
rated on 4–12% Bis–Tris gels (Invitrogen) and
stained with Coomassie blue (Simply Safe Blue
stain; Invitrogen). Bands of interest were ex-
cised from the gel, and protein identification
was performed by the Imperial College Pro-
teomics Facility by tryptic mass fingerprinting,
confirmed by tandem mass spectrometry. The
controls were fromnontransfected cells, treated
identically.
Coimmunoprecipitation of RNAs associated
with hnRNP A2. PC12 cells were lysed and pro-
tein solubilized by agitation with extraction
buffer containing 1% Igepal, 20 mM Tris, 150
mM NaCl, 1 mM EDTA, 0.5% sodium deoxy-
cholate, and protease inhibitor cocktail, pH 7.4,
supplemented with 5 U/ml RNAguard (GE
Healthcare), for 30 min at 4°C. Samples were
centrifuged (50,000  g, 1 h at 4°C), and the
corresponding supernatant was then precleared
with 50 g of protein G–Sepharose. The super-
natant was divided into two and either incu-
bated with 2g/ml high-affinity anti-HA Ab or
an equivalent volume of PBS overnight at 4°C
with constant agitation. An additional 20 g of
protein G–Sepharose was added and incubated for 2 h at 4°C with con-
stant agitation. Beads were washed six times by centrifugation as de-
scribed in the previous section, except that the wash buffers were supple-
mented with 5 U/ml RNAguard. A small aliquot of beads was removed
for protein analysis. The RNA on the remaining beads was extracted with
Trizol (Invitrogen). Total RNA was reverse transcribed with SuperScript
III (Invitrogen) using random primers. PCR was performed using the
primers described above.
Western blotting. Cells were processed for SDS-PAGE as described
previously (Raghib et al., 2001). For detection of endogenous 7 in PC12
cells, cells were lysed on ice by sonication three times for 10 s and centri-
fuged at 3000 g for 3 min. This supernatant was decanted and centri-
fuged at 50,000  g for 4 h at 4°C. The high-speed supernatant and
membrane-containing pellet were then taken up in SDS buffer. Samples
(50 g of cell lysate protein per lane) or immunoprecipitation samples
prepared as above were separated using Novex 4–12% Tris–glycine or
4–12% Bis–Tris NuPAGE gels (Invitrogen) and transferred electro-
phoretically to polyvinylidene fluoride membranes. The membranes
were blocked with 3% BSA/0.02% Tween 20 and then incubated over-
night at room temperature with the relevant primary Ab: rabbit anti-
hnRNPA/BAb (H-200; 1:1000; Autogen Bioclear or Santa Cruz Biotech-
nology); anti-hnRNP A/B monoclonal Ab (F16; 1:1000; Autogen
Bioclear); anti-hnRNP A2monoclonal Ab [EF-67; 1:1000 (Nichols et al.,
2000)]; rabbit anti-HA Ab (1:1000; Sigma), affinity-purified anti-7 Ab
(0.4 g/ml), or anti-2-2(102–117) (1 g/ml) (Brodbeck et al., 2002).
The 2–4 Abs have been described previously (Moss et al., 2003). De-
tection was performed using anti-rabbit or anti-mouse secondary Ab
conjugated to HRP (1 g/ml; Bio-Rad), and bound Abs were detected
using enhanced chemiluminescence (ECL) or ECLPlus reagents (GE
Healthcare). Chemiluminescence or fluorescence was detected using a
Typhoon 9410 Variable Mode Imager (GE Healthcare), set in chemilu-
minescence or fluorescence mode, respectively. Protein bands were
quantified using Imagequant 5.2, on nonsaturated images.
Immunocytochemistry. Cells were fixed and permeabilized for immu-
nocytochemistry essentially as described previously (Brice et al., 1997).
The primary Abs used were affinity-purified anti-7 loop or tail Ab (as
stated, 0.8g/ml) andmousemonoclonal anti-protein disulfide isomer-
ase (1:100; Abcam). Alexa Fluor 594–phalloidin (Invitrogen) was also
used. Secondary Texas Red, FITC, or biotin-conjugated goat anti-mouse
(Invitrogen) or goat anti-rabbit (Sigma) Abs were applied at 10 and 5
g/ml, respectively.When used, Texas Red- or FITC-conjugated strepta-
vidin were applied at 3.33 g/ml. A cyanine 3- tyramide signal amplifi-
cation kit (PerkinElmer Life and Analytical Sciences) was used to detect
7 in SCG neurons. In some experiments, the nuclear dye 4,6-
diamidino-2-phenylindole (DAPI) (300 nM; Invitrogen) was also used to
visualize the nucleus. Cells were mounted in Vectashield (Vector Labo-
ratories) to reduce photobleaching and examined on a confocal laser
scanningmicroscope (Leica TCS SP or Carl Zeiss LSM), using a 40 (1.3
numerical aperture) or 63 (1.4 numerical aperture) oil-immersion ob-
jective. Optical sections were 1.5m. Photomultiplier settings were kept
constant in each experiment, and all imageswere scanned sequentially. In
some experiments, when stated, a conventional fluorescencemicroscope
Figure 2. Effect of C-terminal truncation of 7 on CaV2.2 protein. A, 7 and truncated 7 constructs were expressed at the
expected sizes in COS-7 cells (top,7 I–II loop Ab; bottom7, C-terminal tail Ab). In each lane, the lower band corresponds to the
expected protein molecular weight, and the upper band(s) correspond to either the mature glycosylated form or intermediate
glycosylated species. As expected,7(1–217) and7(1–238) were not detected by the7(C-terminal tail) Ab. The specificity of
the Abs is indicated by the lack of immunostaining in the absence of transfected constructs (). Similar results were obtained in
Xenopus oocytes (data not shown). The same amount of total protein was loaded in each lane (25g). B, Examples of Western
blots showing the effect of7 (i) and7(1–271) (ii) and the lack of effect of7(1–217) (iii) andKV3.1b (iv) on the level of CaV2.2
protein expressed in COS-7 cells. con, Transfection with Kir–AAA cDNA, in place of 7 (see Materials and Methods). The same
amount of total protein was loaded in each pair of lanes (25 g). C, Correlation between the effect of the 7 and its various
C-terminal truncated constructs on the level of CaV2.2 protein with their effect on CaV2.2 IBa shown in Figure 1C. The effect of7,
7(1–217),7(1–271), and7(1–238) on CaV2.2 protein levels represents themean inhibition observed in 3–10 experiments.
The linear fit has a correlation coefficient, r, of 0.936. All error bars are SEM.
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(Axiovert 200; Carl Zeiss) and CCD camera was used; images were cap-
tured using Volocity software (Improvision).
Image processing was performed using NIH ImageJ (http://rsb.info.
nih.gov/ij/). Colocalization analysis was performed using the colocaliza-
tion plugin on images converted to 8 bit. Fluorophores are considered as
colocalized in each pixel when their respective intensities are higher than
the threshold (50) of their channels and when their intensity ratio is

50%.
Electrophysiology. Xenopus oocytes were prepared, injected, and used
for electrophysiology as described previously (Cantí et al., 1999), with the
following exceptions. Plasmid cDNAs for the different voltage-
dependent calcium channel subunits 1, 2-2, 1b, and other con-
structs such as 7 were mixed in equivalent weight ratios at 1 g/l,
unless otherwise stated, and 9 nl was injected intranuclearly, after appro-
priate dilution. The recording solution for CaV2.2-injected oocytes con-
tained the following (inmM): 10 Ba(OH)2, 80 tetraethylammonium-OH,
2 CsOH, and 5 HEPES, pH 7.4 with methanesulfonic acid.
Whole-cell patch-clamp recording using tsA 201 or PC12 cells was
performed and analyzed as described previously (Meir et al., 2000), with
1 mM Ba2 as charge carrier (unless stated) and a holding potential of
100mV.Currents weremeasured 10ms after the onset of the test pulse,
and the average over a 2 ms period was calculated and used for analysis.
Data are expressed as mean	 SEM, and I–V plots were fit with a modi-
fied Boltzmann equation as described previously (Cantí et al., 2001).
Results
The reduction of functional CaV2.2 protein by 7 is mediated
via the C terminus of 7
These experiments were initiated in the light of our previous
finding that coexpression of 7 reduced CaV2.2 protein level, as
well as its functional expression (Moss et al., 2002).We have now
dissected the region of 7 responsible for the inhibitory effect by
making constructs lacking most or part of the cytoplasmic C
terminus,7(1–217) and7(1–238) (Fig. 1A). After cDNA injec-
tion in Xenopus oocytes, when full-length 7 was coexpressed
with CaV2.2, it produced 90% suppression of CaV2.2 currents
(Fig. 1B,C). In contrast, the shorter 7(1–217) transmembrane
construct had very little influence on the expression of CaV2.2
currents (Fig. 1B,C), whereas the 7(1–238) construct produced
a partial reduction of the CaV2.2 current (Fig. 1C). The
C-terminal motif (T/S-SPC) is conserved between 7 and 5.
Although this does not represent a classical PDZ binding motif,
we investigated the importance of this epitope in mediating the
effects of 7 on CaV2.2 currents. A construct lacking these four
amino acids [7(1–271)]was as effective as7 in reducingCaV2.2
IBa (Fig. 1C), indicating that thismotif is not involved in the effect
of 7. Furthermore, addition of a C-terminal tag, such as HA or
CFP, did not affect the ability of 7 to suppress the expression of
CaV2.2 currents. For 7–HA, 72.5	 10.1% (n 5) inhibition of
CaV2.2 currents was observed. These results indicate that a region
of the 7 C terminus between R217 and S271 is responsible for
inhibiting CaV2.2 expression.
The role of the C terminus of 7 was confirmed in tsA 201
cells. Here again the truncated7(1–217) produced no inhibition
of CaV2.2 currents (5.1 	 18.6%) (Fig. 1D,E), whereas full-
length 7 produced 94.9 	 18.6% inhibition (Fig. 1D,E). To
confirm that the 7 protein was responsible for this effect, we
showed that a 7 construct containing a stop codon before the
first transmembrane domain produced no inhibition (Fig.
1D,E). Furthermore, in contrast to the effect of 7 on CaV2.2
currents, it had no significant effect on CaV3.1 currents (Fig.
1D,E).
We raised two antipeptide Abs against 7, to unique peptides
in the linker between transmembrane segments I and II, and in
the C terminus. Neither Ab recognized any protein bands in un-
transfected COS-7 cells (Fig. 2A), and neither Ab cross-reacted
with otherproteins tested (supplemental Fig. 2A–C, available at
www.jneurosci.org as supplemental material). We then con-
firmed that the truncated 7 constructs were all expressed at a
similar level to full-length 7 and that the truncated constructs
were of the expected size (Fig. 2A). Next, we examined the effect
of 7 and its C-terminal truncations on the level of CaV2.2 pro-
Figure 3. Effect of7 and C-terminally truncated7(1–217) on CaV2.2 mRNA stability. A,
Effect of 7 on CaV2.2 mRNA degradation rate. Constructs were expressed in Xenopus oocytes
eitherwithout (f) orwith7 (‚) orwith7(1–217) (). In the absenceof a7 construct, an
equivalent amount of a similar sized transcript, a nonfunctional K channel Kir–AAA cDNAwas
used. After 24 h (T0), actinomycin D (50 g/ml) was added to the medium, and the CaV2.2
mRNA levelsweremeasured at the times shownafter this. Thenumbers of determinations from
individual oocytes are between 6 and 12 for each data point; *p 0.05 compared with CaV2.2
(Student’s t test). The lines are apparent linear fits using errors as weight. B, Bar chart showing
the percentage of CaV2.2,2-2, and KCC1 mRNA present at time t after actinomycin D addi-
tion at time T0. For CaV2.2mRNA turnover, t 9 h. Bars 1–3 are control (black bar; n 11);
7 (white bar, n 7) and7(1–217) (hatched bar; n 8). Bars 4–7 show the percentage
of2-2mRNA and KCC1mRNA present 9 and 24 h, respectively, after actinomycin D addition
for the control condition (black bar; n 8 and 9),7 (white bar; n 9 and 9). These times
were chosen as the percentage of mRNA remaining in control conditions was similar for all
mRNA species. *p  0.05 compared with control, Student’s t test. C, Degradation rate for
endogenous CaV2.2 in the7–CFP PC12 cell line (E; n 3) comparedwith control pcDNA3.1-
transfected PC12 cell line (f; n 5), after differentiation with NGF. The CaV2.2 mRNA level is
expressed as percentage of time 0 (T0), when actinomycin Dwas added. The half-life for endog-
enous CaV2.2 mRNA was 19.5 h in the pcDNA3.1-transfected PC12 cell line. In 7-transfected
PC12 cells, the half-lifewas 9.1 h (**p0.01, Student’s t test). Inset, Reduction of endogenous
CaV2.2mRNA level in7–CFP PC12 cell line comparedwith control pcDNA3.1-transfected PC12
cell line. ***p 0.001 versus control.
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tein. Both 7 and 7(1–271) produced
70% inhibition of CaV2.2 protein,
whereas 7(1–217) caused no reduction
(Fig. 2B). The extent to which CaV2.2 pro-
tein expression was suppressed by 7 and
its truncated constructs was closely corre-
lated with the degree of inhibition of
CaV2.2 IBa observed in Xenopus oocytes
(Fig. 2C). As a control, we showed that ex-
pression of an unrelated protein of similar
size to7 (KV3.1b) had no effect onCaV2.2
protein expression (Fig. 2B).
7 markedly reduces the stability of
CaV2.2 mRNA
Several mechanisms could underlie the
suppression of CaV2.2 currents and
CaV2.2 protein by 7, including suppres-
sion of channel translation, more rapid
protein degradation, suppression of chan-
nel transcription, or increased mRNA
breakdown.We addressed this question by
examining the effect of 7 on the level and
stability of CaV2.2 mRNA. We found that
coexpression of 7 reduced CaV2.2mRNA
levels in two expression systems examined.
In COS-7 cells, there was a 64% reduction
in CaV2.2 mRNA level in the presence of
7, 48 h after transfection (supplemental
Fig. 3, available at www.jneurosci.org as
supplemental material). In agreement
with this, when CaV2.2 and 7 were coex-
pressed in individual Xenopus oocytes,
there was a 66% reduction in CaV2.2
mRNA expression after 24 h (Fig. 3A, see
time 0) when compared with control. We
then examined whether this was attribut-
able to an increase in the rate of degrada-
tion of CaV2.2 mRNA. The transcription
inhibitor actinomycin D was applied 24 h
after injection of the relevant cDNAs into
Xenopus oocytes (at time T0), and mRNA
levels were then determined in individual
oocytes at times up to 24 h thereafter. The
half-life of CaV2.2 mRNA was 7.8	 1.5 h
under control conditions (in agreement
with Schorge et al., 1999), and it showed
more than a twofold decrease to 3.5 	
1.1 h in the presence of 7 (Fig. 3A,B).
Importantly, the truncated 7(1–217)
construct, lacking the C terminus, had no
effect on CaV2.2 mRNA degradation rate
(Fig. 3A,B), in agreement with its lack of
effect on CaV2.2 currents or CaV2.2 pro-
tein (Figs. 1, 2).
The relative mRNA concentrations at
24 h in the absence and presence of 7 are
in agreement with an effect only on the
degradation rate of CaV2.2mRNA and not
on its synthesis rate. Fitting the data to the
equation d[RNA]/dt  kf  kd  [RNA],
where [RNA] is the concentration of RNA
at time t, and kf and kd are the dominant
Figure 4. Short-hairpin RNA constructs knockdown 7 levels in PC12 cells. A, Left, Endogenous 7 (detected using 7 I–II
loop Ab; green) in a differentiated PC12 cell, together with F-actin (Alexa Fluor 594–phalloidin; red) and nuclear staining (DAPI;
blue). Right, Control in the absence of primary7 Ab. Scale bar, 10m (applies to both images). The images are a Z-stack of five
to eight confocal images.B, Fluorescencemicroscopy of PC12 cells stably transfectedwith a human7–CFP construct. These cells
were transiently transfected with YFP and either negative control gnu shRNA (Ctrl; left) or a mixture of three human7 shRNAs
(7; right) and examined after 5 d. Top row, Transfected cells are identified with YFP fluorescence. Middle row, CFP fluorescence
is almost abolished in cells transfected with7 shRNA. Arrowhead in left indicates a cell transfected with the control shRNA that
shows7–CFP fluorescence. Arrows in right indicate two cells transfectedwith7 shRNA that donot show7–CFP fluorescence.
Bottom row, Bright field. Scale bars, 30m. C, Bar chart of the mean percentage of CFP fluorescence in PC127–CFP cells after
transfection with 7 shRNA (white bar) compared with transfection with control shRNA (black bar) or untransfected PC12 cells
(UT, gray bar). ***p 0.001 vs control. D, Effect of rat7 shRNA on7 mRNA level in PC12 cells.7 mRNA was quantified by
q-PCR in PC12 cells transfected with GFP (white bar), negative control shRNA (Ctrl, black bar), or human7 shRNAs:7 96 (red
bar),7 285 (green bar),7 500 (blue bar), or7mix (cyan bar). ***p 0.001 versus control. E, Effect of transfection with7
shRNA on endogenous7 protein levels in PC12 cells. Left, Cells transfected with control shRNA and GFP; right, cells transfected
with rat7 shRNA and GFP. Top row, Bright-field image; middle row, GFP, with transfected cell outlined; bottom row, endoge-
nous7 visualized by immunocytochemistry (red), showing reduced fluorescence in7 shRNA-transfected cell (outlined). Scale
bar, 20 m (applies to all images, which were taken on a conventional fluorescence microscope). F, Quantification of data
including that given in E, showing reduction inmean fluorescence intensity (measured as fluorescence density in arbitrary units)
in 7 shRNA-transfected cells (white bar) compared with control shRNA (Ctrl, black bar) or untransfected cells (UT, gray bar);
***p 0.001 compared with control.
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rate constants for RNA synthesis and degradation, respectively,
then [RNA] at time t  (kf/kd)(1  exp(kd  t)). From the
calculated values of kd, kf 10.1 and 8.8%/h in the absence and
presence of 7, respectively, relative to the control CaV2.2mRNA
level at 24 h, immediately before actinomycin D treatment. Thus,
the data provide no evidence of a marked effect of 7 on the
synthesis rate (kf) of CaV2.2 mRNA, despite a more than twofold
increase in the measured degradation rate.
The effect of 7 on mRNA stability does not affect all calcium
channel subunits, because the degradation rate of 2-2 mRNA
was not affected by 7 coexpression (half-life of25 h) (Fig. 3B)
(supplemental Fig. 4A, available at www.jneurosci.org as supple-
mental material). In agreement with this, the level of 2-2 pro-
tein was little affected by 7 (14.9 	 2.8% reduction; n  6)
(supplemental Fig. 4B, available at www.jneurosci.org as supple-
mental material).
We also investigated the effect of 7 on the stability of KCC1
mRNA (a potassium chloride cotransporter), because it is a
membrane protein of similar mass to CaV2.2, whose mRNA has
some common sequence motifs (see below). Although KCC1
mRNA was much more stable than that of CaV2.2 (half-life of
50.5 h), 7 decreased its half-life to 18.3 h, thus increasing its
mRNA turnover from 28	 11 to 63	 5% in 24 h (n 9) (Fig.
3B). Using the method described above, again we found no evi-
dence for any effect on the synthesis rate. The kfwas calculated to
be 5.0 and 4.1%/h in the absence and presence of 7, respectively,
relative to the control KCC1 mRNA level at 24 h. These results
indicate that the effect of 7 on mRNA degradation rate is selec-
tive for certain mRNAs but not selective for CaV1 mRNAs.
In addition, we demonstrated that 7 had the same effect on
endogenous CaV2.2 mRNA, because, 9 h after actinomycin D
treatment, theCaV2.2mRNA level in a PC12 cell line stably trans-
fected with 7–CFP was reduced by 74% compared with a con-
trol PC12 cell line stably transfected with pcDNA3.1 (Fig. 3C,
inset), and the endogenous CaV2.2mRNA turnover rate was cor-
respondingly enhanced (Fig. 3C). The half-life of CaV2.2 mRNA
was 19.5 h in the pcDNA3.1-transfected
PC12 cell line, which was not significantly
different from that in control PC12 cells
(16.9 h; data not shown). In7-transfected
PC12 cells the half-life was 9.1 h (Fig. 3C).
We found no evidence that the effect of
7 involves the induction of ER stress or
the unfolded protein response, although
this has been postulated as amechanism of
action of TARP 2 (Sandoval et al., 2007).
Coexpression of CaV2.2 with 7 in tsA 201
cells, at a high transfection efficiency using
Amaxa nucleofection, did not increase the
editing of the X binding protein XBP or
induce the C/EBP homologous protein
CHOP expression, both of which are
markers of the induction of the unfolded
protein response (Harding et al., 2002),
whereas these responses were evoked by
exposure of cells to tunicamycin or dithio-
threitol, both of which are well known ac-
tivators of ER stress (D. J. Cox and A. C.
Dolphin, unpublished results).
Knockdown of 7 increases endogenous
CaV2.2 mRNA level in PC12 cells
To study the physiological role of endoge-
nous 7, we chose to silence its expression using RNA interfer-
ence.We first examined the presence and localization of native7
in PC12 cells. Immunocytochemical localization showed that en-
dogenous 7 is expressed in these cells (Fig. 4A) (supplemental
Fig. 5, available at www.jneurosci.org as supplemental material).
We therefore used this cell line to examine the effect of knock-
down of 7. We designed three shRNAs specifically complemen-
tary to sequences in either rat or human 7 mRNA. To confirm
the effectiveness of the 7 shRNAs, we made a PC12 cell line
overexpressing human 7–CFP and showed that, 5 d after trans-
fection, amix of three shRNAs directed against human7mRNA
reduced the 7–CFP protein level in this cell line, by 75% com-
pared with control transfected cells (Fig. 4B,C). We also found
the three corresponding rat 7 shRNAs reduced endogenous 7
mRNA levels in PC12 cells, either individually or when mixed,
whereas the control Drosophila gnu shRNA did not (Fig. 4D).
This would represent a larger reduction in individual transfected
cells, taking into account the incomplete transfection efficiency
(30%). Furthermore, the native 7 protein present endog-
enously in PC12 cells (Fig. 4A,E) was depleted by 70 	 6% in
individual PC12 cells, after transfection with the rat 7 shRNAs
(Fig. 4E,F).
If 7 is playing a physiological role in controlling mRNA sta-
bility, its knockdownmight be expected to have an effect opposite
to 7 overexpression, to increase the endogenous CaV2.2 mRNA
level and enhance its stability. This was indeed the case, because
CaV2.2mRNA levels were increased by30% after rat 7 shRNA
transfection (Fig. 5A), which would represent a larger enhance-
ment in individual transfected cells, taking into account the
transfection efficiency. An expected physiological correlate of
this would be an increase in calcium channel currents in differ-
entiated PC12 cells. In agreement with this, we recorded a 33.1	
4.1% (n 48) increase in peak somatic calcium channel current
density in PC12 cells transfected with rat 7 shRNAs over the
same timescale (Fig. 5B).
Figure 5. Short-hairpin RNA constructs enhance endogenous CaV2.2 mRNA levels and calcium channel currents in PC12 cells.
A, Effect of rat 7 shRNA on endogenous Cav2.2 mRNA level in PC12 cells. Cav2.2 mRNA was quantified by q-PCR in PC12 cells
transfectedwith GFP (white bar), negative control shRNA (Ctrl, black bar), or7 shRNAs:7 96 (gray bar),7 285 (hatched bar),
7 500 (cross-hatched bar), or7 mix (striped bar). ***p 0.001 versus control. B, Top, Representative traces of peak calcium
channel currents recorded from differentiated PC12 cells transfected with control shRNA (left) and 7 shRNA (right). Currents
were elicited by a 100 ms depolarization step to10 mV from a holding potential of100 mV. Bottom, Current–voltage
relationships for the two conditions (f, Ctrl shRNA; E,7 shRNA). The charge carrier was 10 mM Ba 2. The knockdown of7
induces an increase of the peak current (16.1	 0.9 pA/pF; n 48) comparedwith control (12.5	 0.9 pA/pF; n 17; p
0.05).
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7 exists in a complex with RNA
binding proteins
Because PC12 cells contain endogenous
7, they represent a suitable model cell
type in which to search for protein com-
plexes containing 7. For this study, we
used a PC12 cell line stably expressing 7
with a C-terminal HA tag. After immuno-
precipitation of 7–HA from the 7–HA
PC12 cell line and extensive washing, the
presence of coimmunoprecipitating pro-
teins, representing proteins in a complex
with7, was examined by SDS-PAGE (Fig.
6A). Bands of interest, which were present
in the 7–HA immunoprecipitate but ab-
sent from the control, nontransfected
PC12 cells (Fig. 6A, left, arrows, represen-
tative of 3 experiments), were excised and
identified, after tryptic digestion, by pep-
tide mass fingerprinting. The bands la-
beled (1, 36 kDa) and (2, 37 kDa) were
both identified, with 34 and 38% peptide
coverage, respectively, to be hnRNP A2,
which has a number of splice variants of
33–38 kDa (Hatfield et al., 2002). Band 2
also contained hnRNPA3 (40%coverage),
which shares extensive sequence homol-
ogy and is found in a complexwith hnRNP
A2 (Ma et al., 2002). The presence of
7–HA was confirmed by immunoblot-
ting (Fig. 6A, right). Both hnRNP A2 and
hnRNP A3 are members of the hnRNP
A/B subfamily.
We then confirmed that immunopre-
cipitation of 7–HAwas able to pull down
endogenous hnRNP A/B proteins in an-
other system, tsA 201 cells transiently
transfected with 7-HA (Fig. 6B). Three
bands were detected (36–42 kDa), using
hnRNP A/B Abs, which, according to the
antibody specificity and molecular
weights, are likely to represent one ormore
of hnRNPA1, A2, and A3, all of which also
have splice variants. No hnRNP A/B im-
munoreactivity was immunoprecipitated
by 7(1–217)–HA, under the same condi-
tions (Fig. 6B), indicating that these
hnRNPs use the C terminus of 7 for this
interaction. This is in agreement with our
previous finding that the C terminus of 7
is essential for its functional effects. No
hnRNP A/B immunoreactive proteins
were coimmunoprecipitated with an un-
Figure 6. Identification of proteins interacting in a complex with 7. A, Proteins coimmunoprecipitated with 7–HA from
stably transfected PC12 cells. Left, Coomassie blue staining. Right, Western blotting and immunodetection with anti-HA Ab of
immunoprecipitated and control samples separated by SDS-PAGE. Solid arrow indicates7–HA. Small arrows indicate proteins
coimmunoprecipitated with7–HA. Bands 1 and 2 were identified by peptide mass fingerprinting to contain hnRNP A2. Band 2
also contained hnRNP A3. The control lane is untransfected PC12 cells. Position of molecular weightmarkers is shown on the left.
Representative of three experiments. B, Endogenous hnRNP A2 coimmunoprecipitates with transiently transfected 7–HA but
not with7(1–217)–HA in tsA 201 cells. Western blotting and immunodetection with anti-hnRNP A/B Ab (H-200, top row) and
anti-HA Ab (bottom row) of input (left) and HA-immunoprecipitated samples (after 500 mM NaCl wash, right) separated by
SDS-PAGE. Position of molecular weight markers is shown on the left. Blots are representative of three to five independent
experiments, using anti-hnRNP A/B Abs from two different sources. C, CaV1b with a C-terminal HA tag was expressed and
immunoprecipitated as described for7–HA. Its presence in the precipitate is confirmed in the top blot. The control lane is from
cells not transfected with CaV1b–HA. Immunoblotting for endogenous hnRNP A2 shows it is present in the input lanes but
absent from the immunoprecipitate. D, Coimmunoprecipitation of endogenous hnRNP A2 and 7 proteins from PC12 cells.
Western blotting and immunodetection with anti-hnRNP A2 Ab (EF-67, left) and 7 C-terminus Ab (right) of input (left lane of
both panels) and 7 C-terminus Ab-immunoprecipitated samples (right lane of both panels) separated by SDS-PAGE. Control
immunoprecipitations in which 7 Ab was omitted are shown in the middle lane of each panel. Position of molecular weight
markers is indicated between the panels. Blots are representative of two independent experiments. E, The interaction of the C
terminus of hnRNP A2 with the cytoplasmic C-terminal tail of7 was independently confirmed by yeast cotransformation tests.
Lane 1, Positive control (blue reaction product) showing CaV2.2 I–II loop (BI-II) pACT2 and 1b pAS2–1. Lane 2, Interaction
between hnRNP A2 C terminus (hn-C) in pACT2 and7 C terminus (7-C) in pAS2–1. Lanes 3 and 4, Negative controls showing
that the hnRNP A2 C terminus and the7 C terminus do not interact with1b in the alternative vector. The filter was incubated
with the X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside) substrate for 5 h. F, Regions of colocalization of hnRNP A2
with7–CFP (top row) or endogenous7 (bottom row) in SCG neurons. i, Immunolocalization of endogenous hnRNP A2 in SCG
4
neuron cell bodies (top, red; bottom,green). ii, Localizationof
7–CFP (top, blue) or immunolocalization of endogenous7
(bottom, red). iii, Merger of images of i and ii, with the colo-
calized regions shown in white (top) or yellow (bottom). iv,
Colocalized 7 and hnRNP A2 pixels are also shown sepa-
rately for clarity (white). Scale bar, 10m (applies to all im-
ages). No endogenous 7 staining was observed in the ab-
sence of primary Ab (data not shown).
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related HA-tagged protein, HA–CaV1b (Fig. 6C), indicating
that the HA tag is not responsible for this binding.
We also found that pull down of endogenous 7 from un-
transfected PC12 cells, with the 7 C-terminal Ab, was able to
immunoprecipitate endogenous hnRNP A2 (Fig. 6D).
The C terminus of hnRNP A2 interacts directly with the C
terminus of 7
Todeterminewhether the interaction between7 and hnRNPA2
was direct, we used the yeast two-hybrid technique.When the 7
C terminus (residues 201–275) was used as bait, we found an
interactionwith theC terminus of hnRNPA2 (residues 178–342)
(Fig. 6E, lane 2). Because of our previous work in this area, we
used the high-affinity (10 nM) (Leroy et al., 2005) interaction
between the I–II linker of CaV2.2 and the CaV1b subunit as a
positive control (Fig. 6E, lane 1). According to the relative time
taken for colonies to turn blue in a colony-lift filter assay, the
interaction between hnRNPA2 and 7C terminus is weaker than
that between CaV2.2 and CaV1b (data not shown). As negative
controls, we showed that there was no interaction between the C
termini of either hnRNP A2 or 7 and CaV1b (Fig. 6E, lanes 3,
4). Furthermore, the N terminus of hnRNP A2 (amino acids
1–86) was found not to interact with the C terminus of 7 (data
not shown). All these data indicate that7 is likely to be present in
a complex with hnRNP A2. Nevertheless, we cannot rule out that
hnRNP A3, which shows marked homology to hnRNP A2, also
interacts with 7, either directly or by binding to hnRNP A2.
hnRNP A2 colocalizes with 7 in neuronal cytoplasm
We used immunocytochemistry to examine whether 7 and
hnRNP A2 are colocalized in SCG neurons. Although, as ex-
pected, most hnRNP A2 is localized in the nucleus, it is also
observed in small cytoplasmic granules in SCG neurons (Fig.
6Fi). In the somatic cytoplasm, there are clear regions of colocal-
ization of both transfected 7–CFP and endogenous 7 with
hnRNP A2 (Fig. 6Fii,Fiii). This is in agreement with our sugges-
tion that 7 may sequester free hnRNP A2, as outlined in Figure
9, A and B.
CaV2.2 mRNA binds to hnRNP A2
The hnRNP A2 proteins are highly expressed in brain and are
primarily present in the nucleus, in which they bind to particular
nucleotide sequences inmRNA. The combination ofmRNAwith
its many bound proteins, including hnRNP A2, then exits the
nucleus as ribonucleoprotein particles (Pin˜ol-Roma, 1997). The
interaction with hnRNP A2 has been found to stabilize certain
mRNAs for trafficking to a remote site of protein synthesis (Hoek
et al., 1998) and also to enhance translation (Kwon et al., 1999).
In neurons and oligodendrocytes, hnRNP A2 has been impli-
cated in the transport of mRNAs contain-
ing an A2 response element (A2RE) se-
quence, for local protein synthesis (Hoek
et al., 1998; Shyu and Wilkinson, 2000).
We therefore examined whether
CaV2.2 mRNA could be present in a com-
plex with hnRNP A2. We found that the
CaV2.2 mRNA used in this study contains
at least two highly conserved sequences
predicted to bind hnRNP A2 (Table 1),
from the consensus sequence identified in
myelin basic protein (MBP) mRNA
(Ainger et al., 1997). These two sequences
are in constitutive exons, present in all
splice variants of CaV2.2. The sequences preserve A and G at
positions 8 and 9, shown previously to be essential for hnRNPA2
binding and function (Ainger et al., 1997; Shan et al., 2003), and
the sequences are highly conserved in CaV2.2 between species
(Table 1), with related sequences being found in CaV2.1 (data not
shown). We found that a biotinylated 21 base ribonucleotide
corresponding to sequence 1 fromCaV2.2 (Table 1) binds endog-
enous hnRNPA2 from amouse brain lysate, to a similar extent to
the sequence originally described from MBP (Hoek et al., 1998)
(Fig. 7A). We further found that an anti-HA Ab coimmunopre-
cipitated N-terminally HA-tagged hnRNP A2, both with overex-
pressed full-length rabbit CaV2.2mRNA in tsA 201 cells (data not
shown) and also with endogenous CaV2.2 mRNA in PC12 cells
(Fig. 7B). Furthermore, an anti-hnRNP A2 monoclonal Ab co-
immunoprecipitated endogenous hnRNP A2 together with en-
dogenous CaV2.2 mRNA from PC12 cells (Fig. 7C).
hnRNP A2 enhances the expression of CaV2.2 currents, and
this is counteracted by 7
Because hnRNP A2 binds to CaV2.2 mRNA, we wanted to exam-
ine the consequences on calcium channel expression of coexpres-
sion with hnRNP A2. When this construct was coexpressed with
CaV2.2/1b/2-2 in Xenopus oocytes, it produced a significant
enhancement of the peak calcium current amplitude, without
affecting the current kinetics or voltage dependence (Fig. 7D). In
experiments performed in parallel, an unrelated hnRNP (A1),
which is involved in mRNA processing and export but does not
bind to A2RE sequences (Cullen, 2000), did not enhance CaV2.2
calcium currents (Fig. 7D). Thus, hnRNP A2 may enhance
CaV2.2 mRNA stability in Xenopus oocytes or increase its trans-
port to sites of translation. This is compatible with the role pre-
viously attributed to hnRNP A2 that it enhances both transport
and translation of specific mRNAs (Kwon et al., 1999). We also
found that the effect of hnRNP A2 was able to generalize to other
CaV2 channels, because enhancement of CaV2.1/4/2-2 cur-
rents was also observed, the peak IBa at5mV being increased to
194.8 	 19.9% of control (n  28; p  0.0004). CaV2.1 mRNA
contains A2RE sequences that are homologous to those of CaV2.2
(data not shown).
We then investigated whether there was an interaction be-
tween the effects of hnRNP A2 and 7 on calcium channel cur-
rent expression. The inhibitory effect of 7 on CaV2.2 calcium
channel currents, shown in Figure 1B, was found to be concen-
tration dependent (data not shown), and a low concentration of
7 was chosen (1:4 dilution of 7 cDNA), which did not inhibit
CaV2.2 currents in the Xenopus oocyte expression system (Fig.
7E), to examine its interaction with the effect of hnRNP A2. We
found that the enhancement of CaV2.2 currents by hnRNP A2
was prevented by coexpression of this low concentration of 7
Table 1. hnRNP A2mRNA bindingmotifs in CaV2.2 mRNA
Sequence Similarity to consensus sequence in MBP Gene
MBP A2RE GCCAAGGAGCCAGAGAGCAUG 21 bases A2RE
(1) CaV2.2 Cacna1b exon 9
Rabbit GCUAAGGAGCGCGAGAGAGUG 16 of 21 identical
Mouse GCCAAGGAGCGGGAGCGAGUC 15 of 21 identical
Human GCCAAGGAGCGAGAGAGGGUG 18 of 21 identical
(2) CaV2.2 Cacna1b exon 27
Rabbit UCCAAGGAGCUGGAGCGTGAC 13 of 21 identical
Mouse UCCAAGGAGCUGGAGAGGGAC 14 of 21 identical
Human UCCAAGGAGCUGGAGAGGGAC 14 of 21 identical
The binding motif identified in MBP (Hoek et al., 1998) is compared with the two found in CaV2.2. The essential conserved AG bases are in bold, and the
sequences identical to MBP A2RE are underlined. Exon numbering as shown in ENSEMBL.
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(Fig. 7E). This indicates that 7 opposes
the effect of hnRNPA2, supporting the hy-
pothesis that the binding of hnRNP A2 to
its binding site on the C terminus of 7
reduces the amount available to interact
with CaV2.2 mRNA in the cytosol. In
agreement with this interpretation, ex-
pression of the cytosolic C terminus of 7
[7(201–275)], which our yeast two-
hybrid data show to be able to bindhnRNP
A2 (Fig. 6E), was itself able to reduce the
amplitude of CaV2.2 currents. In experi-
ments similar to those shown in Figure 1B,
the peak CaV2.2 IBa current amplitude was
reduced by 70.6 	 4.5% (n  19) relative
to control currents, in the presence of the
C terminus of 7 (data not shown) com-
pared with an 87.4% reduction by full-
length 7 in the same experiment.
Investigation of the subcellular
localization of 7
The topology of 1 and the TARP  pro-
teins indicates that the linker between the
first and second transmembrane domains
is extracellular (Chu et al., 2001), and the
same might be anticipated for 7, which
has a predicted glycosylation site in this
loop (Fig. 1A). We obtained mutational
evidence that 7 is N-glycosylated on N45
in the I–II loop, supporting the proposed
topology (Fig. 8A). However, heterolo-
gously expressed 7 is not inserted in the
plasmamembrane of tsA 201 cells, because
it was not detected with an Ab to this I–II
loop in nonpermeabilized cells (Fig. 8B).
We have observed that 7–CFP, when
heterologously expressed in cultured SCG
neurons, is present, in part, in motile in-
tracellular vesicles (Fig. 8C and data not
shown). These colocalize with 7 I–II loop
Ab immunoreactivity only when the cells
are permeabilized (Fig. 8C). No plasma
Figure 7. Binding of hnRNP A2 to CaV2.2mRNA and effect of hnRNP A2 and7 on CaV2.2 currents.A, Evidence that one of the
two potential A2RE sites in CaV2.2 mRNA binds to hnRNP A2. Endogenous hnRNP A2 (indicated by the arrow) frommouse brain
lysate was pulled down by biotinylated oligonucleotides containing the consensus A2RE site (lane 2) and the potential site in
CaV2.2 (lane 3) but not by beads alone (lane 1) or by a nonspecific sequencewith the same composition as the consensus A2RE site
(lane 4). The hnRNP A2 was detected by immunoblotting with anti-hnRNP A2 Ab (F16). Position of molecular weight markers is
shown on the left. Representative of two experiments. B, Coimmunoprecipitation of endogenous CaV2.2 mRNA associated with
hnRNP A2 in PC12 cells. Two days after transfection with HA–hnRNP A2 (HA-A2, lanes 1 and 3) or hnRNP A2 (A2, lanes 2 and 4),
hnRNP A2 protein was immunoprecipitated (IP) from the whole-cell lysate (lanes 1 and 2) with HA antibody (lanes 3 and 4).
Immunoblots show that HA Ab pulled down hnRNP A2 [top row, anti-hnRNP A2 (EF-67 Ab); middle row, anti-HA]. Coimmuno-
precipitated RNA was extracted, reverse transcribed, and amplified by PCR. A specific PCR product corresponding to the endoge-
nous CaV2.2mRNAwas amplified (35 cycles) only in the condition inwhich hnRNP A2 proteinwas pulled down (bottom row, lane
3). C, Left, Endogenous hnRNPA2 proteinswere immunoprecipitated fromPC12 cellswith anti-hnRNPA2Ab EF-67 (top row, lane
2). In this condition, a specific PCR product corresponding to the endogenous CaV2.2mRNAwas also amplified (35 cycles, bottom
row). CaV2.2mRNAwas not detected in the control in which antibodywas omitted (lane 3). Right, The immunoprecipitationwas
repeated, including an acetone precipitation step, to confirm the presence of endogenous hnRNP A2. D, Enhancement by hnRNP
A2but not hnRNPA1of CaV2.2 currents recorded fromXenopusoocytes. Left, Example traces elicitedby50ms stepdepolarizations
to between 40 and 0 mV in 10 mV steps, from a holding potential of 100 mV for CaV2.2/1b/2-2 (top traces) or
CaV2.2/1b/2-2 plus hnRNP A2 (bottom traces). The charge carrier was 10 mM Ba
2. Right, Bar chart shows the effect of
hnRNP A2 coexpression with CaV2.2/1b/2-2 on peak CaV2.2 IBa amplitude, expressed relative to the mean peak control
current in eachexperiment. Control (blackbar;n18), for bothgroups taken fromexperimentsdirectly comparinghnRNPA1and
hnRNP A2: hnRNP A2 (white bar; n 21) and hnRNP A1 (hatched bar; n 19). These data are pooled from two separate
4
experiments showing similar results. Statistical significance,
*p 0.05, **p 0.01 (one-way ANOVA and Bonferroni’s
post hoc test). E, Inhibition of the hnRNP A2-mediated en-
hancementof IBa inXenopusoocytes by a lowconcentrationof
7. Bar chart compares the effect of two concentrations of7
cDNA (7: CaV2.2 ratio 1 and 0.25) and also shows the lack of
enhancement by hnRNP A2 on peak CaV2.2 IBa amplitude,
when coexpressed with the lower concentration of 7 (7:
CaV2.2 ratio 0.25). Data are expressed as a percentage of the
mean peak control CaV2.2 current in each experiment, and all
data were recorded 2 d after cDNA injection. Control in the
absence of 7 or hnRNP A2 (white bars);  7 (ratio 1;
hatched bar),  7 (ratio 0.25; cross-hatched bar), 
hnRNP A2 (black bar, from data obtained in the same experi-
ments),hnRNPA2and7 (ratio0.25; graybar).Numberof
determinations given above each bar. These data are pooled
from five different batches of oocytes, in all of which similar
results were observed. Statistical significance, **p  0.01
(one-way ANOVA and Bonferroni’s post hoc test).
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membrane staining was detected in the absence of cell permeabi-
lization (Fig. 8C). We also found that neither endogenous 7
(Fig. 4A) nor 7–CFP (Fig. 4B and data not shown) localized to
the plasma membrane in PC12 cells. The localization of 7 is
therefore on intracellular membranes in all the cells we have ex-
amined.We found that the distribution of7–CFPpartially over-
lapped with that of an ER marker in the somata of SCG neurons
microinjected with 7–CFP and pDsRed2–ER (Fig. 8D). It
was also found in vesicular structures, which were negative for
the ER marker (Fig. 8D). Similar results were obtained in
PC12 cells using a different ER marker, protein disulfide
isomerase (data not shown).
Discussion
We have described previously the identifi-
cation of two genes that encode 5 and 7,
by their homology with the mouse starga-
zin gene (cacng2) and have cloned and ex-
pressed the cDNA for both human and
mouse 7 (Moss et al., 2002). The 7 pro-
tein contains 275 amino acids with an es-
timated protein mass of 31 kDa and has
four predicted transmembrane-spanning
domains with intracellular N and C ter-
mini and a consensus N-glycosylation se-
quence in the loop between the first two
transmembrane segments (Fig. 1A). To-
gether with the other -like proteins, it be-
longs to the claudin superfamily,members
of which play diverse roles in cellular phys-
iology (Sanders et al., 2001). Initially, the
novel1-like proteins (2–8)were inves-
tigated as potential calcium channel sub-
units (Letts et al., 1998; Klugbauer et al.,
2000; Kang et al., 2001; Rousset et al., 2001;
Sharp et al., 2001;Moss et al., 2003). How-
ever, we have shown that, although the hu-
man 2 and 4 TARPS are expressed in
Purkinje neurons, there was no effect of
these proteins on calcium currents com-
posed of CaV2.1/4/2-2, a combination
that mimics the major calcium channel
complement in Purkinje cells (Moss et al.,
2003). More recently, these proteins have
been shown to have roles in trafficking and
localization of AMPA glutamate receptors
(Tomita et al., 2003, 2004; Fukata et al.,
2005; Kato et al., 2007). Together with the
data presented here, these findings suggest
that  proteins may play diverse and pos-
sibly multiple roles in intracellular
trafficking.
In our original study, we showed that
coexpression with 7 almost completely
abolished Ba2 current through N-type
CaV2.2 channels expressed from cDNA in
both Xenopus oocyte and COS-7 cell ex-
pression systems (Moss et al., 2002). Sev-
eral mechanisms could underlie the sup-
pression of CaV2.2 currents by 7 protein,
but we have now identified that a major
mechanism of suppression of CaV2.2 cur-
rents by 7 results from a decrease in
CaV2.2 mRNA stability. This process re-
quires the cytoplasmic C terminus of 7, because all its effects, to
inhibit CaV2.2 current and protein expression and to increase the
rate of mRNA degradation, are completely prevented by the re-
moval of most of the C terminus of 7. It is well known that the
effect of overexpression of a protein does not necessarily reflect its
physiological function, because an overexpressed proteinmay act
to sequester interacting partners. However, our evidence indi-
cates that the regulation of the stability of CaV2.2 mRNA, and
potentially othermRNAs, represents an important role for native
7. This evidence stems from the finding that knockdown of
endogenous 7 in PC12 cells, using 7 shRNA, substantially en-
Figure 8. Subcellular localization of 7. A, Western blotting of a 7 mutant in which the potential glycosylation site, N45 is
mutated to A, and immunodetection with anti-7 I–II loop Ab. Lane 1, 7; lane 2, 7 N45A. The reduction in mass and
sharpening of the band indicates that7 is normally glycosylated at this site. Positions ofmolecularweightmarkers are shownon
the left. The data are representative of two independent experiments.B, Immunodetection of transiently transfected7 (green)
in nonpermeabilized (left) and permeabilized (right) tsA 201 cells, using7 I–II loop Ab. The nuclear stain DAPI (blue) was used
as a cell marker. Scale bar, 100m (applies to both images). No immunostaining was observed in any field in the absence of
permeabilization.C, Immunostaining for7using I–II loopAb (Texas Red secondaryAb, left) colocalizes completelywith7–CFP
(middle), as shown by yellow regions in merged image (right), in permeabilized (top row) but not nonpermeabilized (bottom
row) SCG neurons. Scale bar, 40m (applies to all images).D, Partial colocalization of7–CFP and an ERmarker in SCG neurons.
Left,7–CFP; middle, ER marker (ER-DsRed); right, overlay showing colocalization of DsRed with7–CFP (white). Scale bar, 10
m (applies to all images).
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hances their endogenous CaV2.2 mRNA level and enhances en-
dogenous somatic calcium currents after differentiation.
We have subsequently identified by coimmunoprecipitation
from a PC12 cell line stably transfected with 7–HA, that the
RNA binding protein hnRNP A2 is coimmunoprecipitated with
7. hnRNP A2 has been found to be involved in the stability,
trafficking, and localization of particular mRNAs and has been
identified to bind to several different mRNA sequences, includ-
ing CGG repeats (Sofola et al., 2007), AU-rich elements (Hamil-
ton et al., 1999), and a well characterized binding motif termed
A2RE (Ainger et al., 1997; Shan et al., 2003; Fa¨hling et al., 2006).
Most hnRNP A2 is localized in the nucleus, in which it binds to
specific sequences in transcribed mRNA, and is involved in
mRNA export into the cytoplasm (for review, see Shyu and
Wilkinson, 2000) and subsequently in trafficking and enhance-
ment of translation for those mRNAs containing an A2RE se-
quence (Kwon et al., 1999). Our yeast two-hybrid data indicates
that 7 C terminus binds directly to hnRNP A2, and our subcel-
lular localization data for 7 indicate that this interaction will
occur on intracellular membranes within the cytoplasm (as de-
picted in Fig. 9B).
There are twohighly conserved consensus hnRNPA2-binding
A2RE motifs in the CaV2.2 mRNA used in this study (Table 1)
that contain the conserved A and G at positions 8 and 9, which
have been found to be a prerequisite for binding of hnRNP A2
(Ainger et al., 1997). There are also several other, less well con-
served, A2REmotifs in the CaV2.2mRNA sequence thatmay also
be functional (data not shown). Here we have demonstrated that
hnRNP A2 binds to one of the conserved sequences (Table 1,
sequence 2) and, by homology, is highly likely to bind to the other
sequence. Furthermore, hnRNP A2 coimmunoprecipitates en-
dogenous CaV2.2 mRNA from PC12 cells. We suggest that
hnRNP A2 normally binds to sequences on CaV2.2 mRNA in the
nucleus, and, when the ribonucleoprotein particle so formed ex-
its the nucleus, it is transported to its site of translation and also
protected from degradation (as depicted in Fig. 9A). A similar
mechanism of interaction with hnRNPA2 has been proposed for
MBP mRNA that contains a canonical A2RE sequence (Hoek et
al., 1998). It has also been shown that hnRNP A2 itself is subject
to transport (Brumwell et al., 2002). Indeed, the hnRNP A/B
proteins have been identified as components in isolated RNA-
transporting granules (Kanai et al., 2004). Furthermore, theDro-
sophila homolog Hrp48 is involved in the localization of oskar
mRNA (Huynh et al., 2004; Yano et al., 2004). Other RNA bind-
ing proteins, such as Staufen, have been shown to have an effect
on both localization and decay of specificmRNAs (Broadus et al.,
1998; Kim et al., 2005).
Our results provoke the hypothesis that 7 is involved in the
regulation of hnRNP A2 function, as depicted in Figure 9B. 7
may sequester hnRNP A2, and this may be the mechanism
whereby the stability of specific mRNAs, including that of
CaV2.2, are compromised. Furthermore, our results indicate that
native, as well as heterologously expressed, 7 both influence the
physiological regulation of CaV2.2 mRNA stability, because
knockdown of native 7 increased endogenous CaV2.2 mRNA
andCaV2.2 current levels. This indicates that endogenous7may
function to limit the availability of cytoplasmic hnRNP A2. A
related pathological mechanism of hnRNP A2 sequestration by
binding to expanded CGG repeats of FMR1 mRNA has been
proposed recently to occur in fragile X-associated tremor/ataxia
syndrome (Sofola et al., 2007). It will be of interest to examine
whether a similar interaction occurs with other triplet repeat
diseases.
The expression of CaV2.2 channel proteins may be particu-
larly vulnerable to a reduction in available hnRNPA2 because the
mRNAdegradation rate of CaV2.2 is relatively high.Nevertheless,
other mRNAs are also likely to be similarly affected, and we show
that the degradation of KCC1 mRNA, which also contains an
A2RE sequence, is also enhanced by 7.
Both CaV2.2 (Mori et al., 1991) and 7 (Moss et al., 2002) are
selectively expressed in neurons. CaV2.2 channel expression and
function is dynamically regulated both physiologically (Pravet-
Figure9. Diagramof proposed function of7.A, The physiological distribution of hnRNPA2
and7. The hnRNPA2 (red circles) is localized primarily in the nucleus inwhich it binds to A2RE
sequences on mRNAs and exits to the cytoplasm with these mRNAs, including that of CaV2.2
(green). This is thought to stabilize certainmRNAs, reducingdegradationand therefore enhanc-
ing expression. Our results suggest thismay be the case for CaV2.2. hnRNP A2may also stabilize
the mRNAs for transport.7 (dark blue) is present on the ER and is also associated with motile
vesicles. B, After overexpression of 7, it may sequester cytoplasmic hnRNP A2 and therefore
increase degradation of CaV2.2 mRNA.
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toni et al., 2000; Inchauspe et al., 2004) and in pathology (Hen-
driksen et al., 1997). It is of interest that CaV2.2 channels are
functionally most important in early development, and, in many
instances, their role is later substituted by P/Q-type calcium
channels (CaV2.1), in terms of both somatic currents (Salgado et
al., 2005) and synaptic transmission (Iwasaki et al., 2000). Over a
similar time period, we found that 7 expression is strongly up-
regulated (M. Nieto-Rostro and A. C. Dolphin, unpublished re-
sults). It is now recognized from many studies that regulation of
mRNA stability is a very important part of the posttranscriptional
control of expression of numerous genes (Wilusz and Wilusz,
2004).
There are indications that CaV2.2 mRNA is subject to trans-
port, because it has been identified in dendritic growth cones
(Crino and Eberwine, 1996) and in processes of motor neurons
(Jablonka et al., 2007). Furthermore, N-type calcium channels
are localized in the presynaptic terminals of peripheral neurons,
such as DRG neurons, and local synthesis of transmembrane
proteins has been demonstrated recently in axons and axonal
growth cones (Brittis et al., 2002). It will be of great interest in the
future to examine whether hnRNP A2 affects the transport of
CaV2 family mRNAs, to regions distinct from the cell soma.
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